-
Mashup Score: 46SAGE updates COVID-19 vaccination guidance - 1 year(s) ago
Following its 20-23 March meeting, WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) revised the roadmap for prioritizing the use of COVID-19 vaccines, to reflect the impact of Omicron and high population-level immunity due to infection and vaccination. The roadmap continues SAGE’s prioritization of protecting populations at the greatest risk of death and severe disease from…
Source: www.who.intCategories: Expert Picks, Latest HeadlinesTweet-
. @WHO Strategic Advisory Group of Experts on Immunization (SAGE) updated #COVID19 vaccination guidance https://t.co/4yq7CQTl3F
-
-
Mashup Score: 6
Older people, those with multimorbidity, and those with specific underlying health conditions remain at increased risk of COVID-19 hospitalisation and death after the initial vaccine booster and should, therefore, be prioritised for additional boosters, including novel optimised versions, and the increasing array of COVID-19 therapeutics.
Source: The LancetCategories: Expert Picks, Latest HeadlinesTweet-
PAXLOVID: And my fellow ID doctors, it is this same population (immunosuppressed, older) who need yearly #boosters in addition to #Paxlovid if infected in my opinion. This study tells us who is still at risk after 2 dose of vax https://t.co/d59GiAajp2 https://t.co/s0KtwwLw12
-
-
Mashup Score: 0The mRNA COVID-19 Boosters Protect Against XBB and XBB15 - 1 year(s) ago
In the CDC’s latest Morbidity and Mortality Weekly Report, investigators reported the Moderna and Pfizer-BioNTech updated vaccines helped prevent acute infection from the latest Omicron mutations.
Source: OncLiveCategories: Infectious Disease, Latest HeadlinesTweet-
The #CDC is reporting the bivalent mRNA (Pfizer-BioNTech, and Moderna) #boosters provided protection against symptomatic #COVID19 infection of the XBB and XBB15 variants for at least 3 months in individuals who received 2-4 monovalent vaccine doses. https://t.co/MRPUiC30VF
-
-
Mashup Score: 4
A recent swirl of misinformation linking the rise of new coronavirus variants to vaccination has cast a spotlight on XBB.1.5, raising concerns that it could limit booster uptake.
Source: Washington PostCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The newest #omicron variant is becoming the most dominant #COVID19 strain in the U.S. Getting updated #boosters and masking in crowded indoor spaces remains crucial to avoid another wave. https://t.co/lClTOSoetw
-
-
Mashup Score: 4
Paul Offit, MD, also argues that boosting should be reserved for older or vulnerable individuals
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Omicron-targeting #bivalent #boosters likely conferred no extra protection against COVID-19 over the original #mRNA products due to immune imprinting, according to vaccine expert @DrPaulOffit of @ChildrensPhila. Read the full article: https://t.co/fp6ebJs5UF https://t.co/5IC6fXaEH5
-
-
Mashup Score: 1
AMA’s Vice President of Science, Medicine and Public Health Andrea Garcia, JD, MPH, explains what you need to know about the latest Omicron subvariant. Also …
Source: YouTubeCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
What you need to know about the latest #Omicron subvariant, bivalent #boosters and protecting kids from the #flu as they return to school after the holidays. https://t.co/TZWsVs3MN6 https://t.co/IWnKA99lai
-
-
Mashup Score: 1
Learn about the science driving recommendations for children as young as 6 months old to get protection from highly contagious variants of SARS-CoV-2.
Source: American Medical AssociationCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Parents: here's what you need to know about #COVID19 #boosters for children as young as 6 months old. https://t.co/CU8TXf9fnR
-
-
Mashup Score: 3Bivalent Booster Provides Protection Against Severe COVID-19, Possible Hospitalization - 1 year(s) ago
In a new CDC report, these immunizations aid against emergency department and urgent care encounters in immunocompetent adults.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
In a new #CDC report, these immunizations were found to protect against emergency department and urgent care encounters in immunocompetent adults. #bivalent #COVID19 #boosters https://t.co/0hzLrmgzQt
-
-
Mashup Score: 0Bivalent Booster Provides Protection Against Severe COVID-19, Possible Hospitalization - 1 year(s) ago
In a new CDC report, these immunizations aid against emergency department and urgent care encounters in immunocompetent adults.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
In a new #CDC report, these immunizations aid against emergency department and urgent care encounters in #immunocompetent adults. #Boosters https://t.co/0hzLrmgzQt
-
-
Mashup Score: 4FDA authorizes updated Covid-19 boosters for youngest children - 1 year(s) ago
The FDA amended the emergency use authorizations for the updated Moderna and Pfizer-BioNTech Covid-19 boosters, to allow their use in children aged 6 months and older.
Source: STATCategories: Latest Headlines, PediatricsTweet-
FDA authorizes updated Covid-19 #boosters for youngest children https://t.co/misfKzzHu9 via @statnews
-
BOOSTERS FOR HIGH RISK: Sensible from @WHO immunization experts #covid19 #boosters given high levels of population immunity from vax + infection now. Only for high-priority group (age, immunocompromised) at 6-12 months from last (annual not yet endorsed) https://t.co/C0HVRPP5gg